Literature DB >> 22281912

Hyperbaric oxygen therapy as an adjuvant treatment for pyoderma gangrenosum.

Wilson Albieri Vieira1, Luisa Raizer Barbosa, Ligia Marcio Mario Martin.   

Abstract

Pyoderma Gangrenosum is a rare neutrophilic dermatosis of skin and subcutaneous tissue characterized by a painful and progressive necrotizing process. The management of pyoderma gangrenosum often requires systemic drug therapy, such as corticosteroids, sulfones or immunosuppressants, either alone or in combination. Several reports in the literature document the successful treatment of pyoderma gangrenosum with hyperbaric oxygen therapy. In our case, hyperbaric oxygen therapy associated with corticoids and immunosuppressants promoted healing of large and very painful lesions in an adolescent girl with an excellent outcome, including rapid wound closure and decreased discomfort.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22281912     DOI: 10.1590/s0365-05962011000600022

Source DB:  PubMed          Journal:  An Bras Dermatol        ISSN: 0365-0596            Impact factor:   1.896


  5 in total

Review 1.  Pyoderma gangrenosum after orthopaedic or traumatologic surgery: a systematic revue of the literature.

Authors:  Stephan Ebrad; Mathieu Severyns; Ahmed Benzakour; Benoit Roze; Christian Derancourt; Guillaume-Anthony Odri; Jean-Louis Rouvillain
Journal:  Int Orthop       Date:  2017-11-08       Impact factor: 3.075

2.  Pyoderma gangrenosum: skin grafting and hyperbaric oxygen as adjuvants in the treatment of a deep and extensive ulcer.

Authors:  Fernanda Mendes Araújo; Rogério Nabor Kondo; Lorivaldo Minelli
Journal:  An Bras Dermatol       Date:  2013 Nov-Dec       Impact factor: 1.896

Review 3.  Is there a role for hyperbaric oxygen therapy in the treatment of refractory wounds of rare etiology?

Authors:  Pasquale Longobardi; Klarida Hoxha; Michael H Bennett
Journal:  Diving Hyperb Med       Date:  2019-09-30       Impact factor: 0.887

4.  Hyperbaric oxygen therapy for pyoderma gangrenosum associated with ulcerative colitis.

Authors:  Hyun Il Seo; Hyun-Ju Lee; Koon Hee Han
Journal:  Intest Res       Date:  2018-01-18

Review 5.  Pyoderma Gangrenosum: An Updated Literature Review on Established and Emerging Pharmacological Treatments.

Authors:  Carlo Alberto Maronese; Matthew A Pimentel; May M Li; Alex G Ortega-Loayza; Angelo Valerio Marzano; Giovanni Genovese
Journal:  Am J Clin Dermatol       Date:  2022-05-24       Impact factor: 6.233

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.